(Q39124552)

9 September 2017

MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment (English)

1 reference

9 September 2017

1 reference

hepatocellular carcinoma

1 reference

Fan Yang

1

1 reference

9 September 2017

Qing-jun Li

2

1 reference

9 September 2017

Zhen-bin Gong

3

1 reference

9 September 2017

Liang Zhou

4

1 reference

9 September 2017

Nan You

5

1 reference

9 September 2017

Su Wang

6

1 reference

9 September 2017

Xiao-lei Li

7

1 reference

9 September 2017

Jun-jie Li

8

1 reference

9 September 2017

Jia-ze An

9

1 reference

9 September 2017

De-sheng Wang

10

1 reference

9 September 2017

Yong He

11

1 reference

9 September 2017

Ke-feng Dou

12

1 reference

9 September 2017

11 July 2013

1 reference

Technology in Cancer Research and Treatment

9 September 2017

1 reference

9 September 2017

13

1 reference

9 September 2017

1

1 reference

9 September 2017

77-86

1 reference

Primary liver cancer: worldwide incidence and trends

9 September 2017

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

MicroRNA-directed cleavage of HOXB8 mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

21 January 2018

The microRNA Registry

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Induction of Bcl-2 expression by hepatitis B virus pre-S2 mutant large surface protein resistance to 5-fluorouracil treatment in Huh-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Identification of metastasis-related microRNAs in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Expression and role of Bcl-xL in human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

miR-221 overexpression contributes to liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

miRNA-34a is associated with docetaxel resistance in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500364

21 January 2018

Identifiers

DOI

10.7785/TCRT.2012.500364

1 reference

9 September 2017

1 reference